Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-135"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101124.15.3-135"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, I naturally voted in favour of Mr Fjellner’s report, which, in addition to talking about information for patients on product leaflets and the individual packaging of medicines, mainly focuses on the behaviour of pharmaceutical companies. Until recently many of them combined information on the medicine with their own advertising. In my opinion, they were influencing patients in a non-objective way to take note of a particular product.
I am in favour of patients having the best, and most up-to-date information, which is approved at the same time as a new medicine is approved, for example, and I believe we have made a major contribution to this. High quality information must also be provided, of course, in the mother-tongue on the Internet, which is the modern medium of communication. I am pleased that, by adopting this report, we have actually reduced the disparity between EU countries that are less developed in this area, and I am pleased that doctor-patient relationships have not been impaired in any way. That is the main source of information."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples